Jonathan Zalevsky

Chief R&D Officer, Nektar Therapeutics

Bought, 12 months

$0.0M

Sold, 12 months

$1.0M

Companies

Latest trade

Aug 18, 2026

Companies

Nektar TherapeuticsChief R&D Officer −$1.0M

Trades

NKTR Sold 186 shares at $71.98 $0.0M Aug 18

NKTR Sold 5,681 shares at $70.00 · planned $0.4M Jun 30

NKTR Sold 5,538 shares at $60.71 · planned $0.3M Jun 15

NKTR Sold 199 shares at $65.51 $0.0M May 19

NKTR Sold 180 shares at $73.00 $0.0M Feb 18

NKTR Sold 3,867 shares at $35.67 · planned $0.1M Jan 20

NKTR Sold 1,157 shares at $54.28 $0.1M Nov 25

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.